XL-844

CAS No. 631864-00-1

XL-844( EXEL-9844 | EXEL9844 | XL844 )

Catalog No. M15387 CAS No. 631864-00-1

A potent, specific, orally available, ATP competitive inhibitor of Chk1 and Chk2 with Ki of 2.2 nM and 0.07 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    XL-844
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, specific, orally available, ATP competitive inhibitor of Chk1 and Chk2 with Ki of 2.2 nM and 0.07 nM, respectively.
  • Description
    A potent, specific, orally available, ATP competitive inhibitor of Chk1 and Chk2 with Ki of 2.2 nM and 0.07 nM, respectively; increases gemcitabine-induced H2AX phosphorylation, blocks Cdc25A phosphorylation, and induces premature mitotic entry; significantly enhances gemcitabine antitumor activity in a PANC-1 xenograft model.Blood Cancer Phase 1 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    EXEL-9844 | EXEL9844 | XL844
  • Pathway
    Angiogenesis
  • Target
    Chk
  • Recptor
    Chk
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    631864-00-1
  • Formula Weight
    287.323
  • Molecular Formula
    C14H17N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC=C(C(=C1)NC(=O)NC2=NC=CN=C2)OCCCN
  • Chemical Name
    1-[2-(3-aminopropoxy)phenyl]-3-pyrazin-2-ylurea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Riesterer O, et al. Invest New Drugs. 2011 Jun;29(3):514-22. 2. Matthews DJ, et al. Cell Cycle. 2007 Jan 1;6(1):104-10.
molnova catalog
related products
  • Prexasertib dihydroc...

    A potent, selective, ATP-competitive inhibitor of CHK1 with Ki of 0.9 nM.

  • PHI-101

    PHI-101 is an orally available and selective checkpoint kinase 2 (Chk2) inhibitor for the study of refractory acute myelogenous leukemia (AML) and ovarian cancer.

  • PF-00477736

    PF-00477736 (PF-477736) is a potent, selective, ATP-competitive inhibitor of Chk1 with Ki of 0.49 nM, also inhibits Chk2 (Ki=47 nM) and poorly inhibits CDK1 activity (Ki=9.9 uM).